[1]Strohmaier K,Franze R,Adam K H. Location and characterization of the antigenic portion of the FMDV immunization protein[J]. Journal of General Virology,1982,59(2):295-306.
[2]Cao Y M,Lu Z J,Liu Z X. Foot-and-mouth disease vaccines:progress and problems[J]. Expert Review of Vaccines,2016,15(6):783-789.
[3]Doel T R. FMD vaccines[J]. Virus Research,2003,91(1):81-99.
[4]Rodriguez L. Foot-and-mouth disease virus vaccines[J]. Vaccine,2011,27(S4):D90-D94.
[5]孙小涵,张碧成,张强,等. 非致病性大肠杆菌鞭毛蛋白对O型口蹄疫病毒的佐剂效果[J]. 中国农业科学,2017,50(9):1714-1722.
[6]Sheldrake R F,Romalis L F,Saunders M M. Serum and mucosal antibody responses against Mycoplasma hyopneumoniae following intraperitoneal vaccination and challenge of pigs with M hyopneumoniae[J]. Research in Veterinary Science,1993,55(3):371-376.
[7]Okamba F R,Arella M,Music N,et al. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine[J]. Vaccine,2010,28(30):4802-4809.
[8]Lee S H,Lee S W,Chae C,et al. A recombinant chimera comprising the R1 and R2 repeat regions of M.hyopneumoniae P97 and the N-terminal region of A. pleuropneumoniae Apx Ⅲ elicits immune responses[J]. BMC Veterinary Research,2014,10:43.
[9]Smith K D,Andersen-Nissen E,Hayashi F,et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility[J]. Nature Immunology,2004,5(4):451.
[10]Hong S H,Byun Y H,Nguyen C T,et al. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection[J]. Vaccine,2012,30(2):466-474.
[11]Skountzou I,Martin M D,Wang B Z,et al. Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine[J]. Vaccine,2010,28(24):4103-4112.
[12]Le Moigne V,Robreau G,Mahana W. Flagellin as a good carrier and potent adjuvant for Th1 response:study of mice immune response to the p27 (Rv2108) Mycobacterium tuberculosis antigen[J]. Molecular Immunology,2008,45(9):2499-2507.
[13]Honko A N,Sriranganathan N,Lees C J,et al. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis[J]. Infection and Immunity,2006,74(2):1113-1120.
[14]Albert M J,Mustafa A S,Islam A,et al. Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model[J]. MBio,2013,4(3):e00213-e00246.
[15]Delaney K N,Phipps J P,Johnson J B,et al. A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice[J]. Viral Immunology,2010,23(2):201-210.
[16]Petrovsky N,Aguilar J C. Vaccine adjuvants:current state and future trends[J]. Immunology and Cell Biology,2004,82(5):488-496.
[17]Hou J E,Liu Y,Hsi J,et al. Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice[J]. Human Vaccines & Immunotherapeutics,2014,10(5):1274-1283.
[18]Miyata T,Harakuni T,Taira T,et al. Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice[J]. Vaccine,2012,30(5):948-958.
[19]陈里新,靳玉珠,扈荣良. 口蹄疫疫苗的研究进展[J]. 中国生物制品学杂志,2009,22(3):301-304.
[20]Gibbens J C,Sharpe C E,Wilesmith J W,et al. Descriptive epidemiology of the 2001 foot-and-mouth disease epidemic in Great Britain:the first five months[J]. Veterinary Record,2001,149(24):729-743.
[21]Barate A K,Cho Y,Truong Q L,et al. Immunogenicity of IMS 1113 plus soluble subunit and chimeric proteins containing Mycoplasma hyopneumoniae P97 C-terminal repeat regions[J]. FEMS Microbiology Letters,2014,352(2):213-220.
[22]陈超,李媛,郭丹,等. 猪肺炎支原体p97 C末端基因重组腺病毒的构建及其免疫效果[J]. 微生物学报,2009,49(4):465-470.
[23]韦艳娜,熊祺琰,董璐,等. 猪肺炎支原体P97R1抗原免疫刺激复合物的制备及对活疫苗免疫刺激能力的增强作用研究[J]. 中国预防兽医学报,2013,35(12):1016-1019.
[24]Batah J,Denève-Larrazet C,Jolivot P A,et al. Clostridium difficile flagella predominantly activate TLR5-linked NF-kappa B pathway in epithelial cells[J]. Anaerobe,2016,38:116-124.
[25]Tahoun A,Jensen K,Corripio-Miyar Y,et al. Functional analysis of bovine TLR5 and association with IgA responses of cattle following systemic immunisation with H7 flagella[J]. Veterinary Research,2015,46:9.
[26]Stratmann T. Cholera toxin subunit B as adjuvant-an accelerator in protective immunity and a break in autoimmunity[J]. Vaccines,2015,3(3):579-596.
[27]孙小涵. 非致病性大肠杆菌鞭毛蛋白增强FMDV免疫原性的研究[D]. 长春:吉林农业大学,2017.
[1]程汉,曹军平,史明基.口蹄疫、猪瘟和高致病性猪蓝耳病3种疫苗不同组合
对猪的免疫效果评价[J].江苏农业科学,2013,41(05):188.
Cheng Han,et al.Immunization of different combinations of vaccines of aftosa,swine fever and high pathogenic blue ear pig disease on swine[J].Jiangsu Agricultural Sciences,2013,41(11):188.
[2]于秋良,潘百明,骆永泉,等.液相阻断酶联免疫和正向间接血凝试验检测猪口蹄疫抗体[J].江苏农业科学,2013,41(08):207.
Yu Qiuliang,et al.Detection of FMD antibodies by liquid phase blocking enzyme-linked immunosorbent and indirect hemagglutination test[J].Jiangsu Agricultural Sciences,2013,41(11):207.
[3]华利忠,吴文开,邵国青.发酵床与传统水冲圈模式下猪瘟、蓝耳病及口蹄疫血清抗体差异调查[J].江苏农业科学,2014,42(09):178.
Hua Lizhong,et al.Study on differences in serum antibody of CSFV,PRRSV and FMD between fermentation bed model and traditional water ring model[J].Jiangsu Agricultural Sciences,2014,42(11):178.